0000899243-21-048205.txt : 20211214 0000899243-21-048205.hdr.sgml : 20211214 20211214190039 ACCESSION NUMBER: 0000899243-21-048205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211212 FILED AS OF DATE: 20211214 DATE AS OF CHANGE: 20211214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hernandez Joseph CENTRAL INDEX KEY: 0001598384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39802 FILM NUMBER: 211492407 MAIL ADDRESS: STREET 1: C/O MICROLIN BIO, INC. CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clarus Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001817944 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851231852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 SKOKIE BOULEVARD, SUITE 340 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: (847) 562-4300 MAIL ADDRESS: STREET 1: 555 SKOKIE BOULEVARD, SUITE 340 CITY: NORTHBROOK STATE: IL ZIP: 60062 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Acquisition Corp. DATE OF NAME CHANGE: 20200713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-12 0 0001817944 Clarus Therapeutics Holdings, Inc. CRXT 0001598384 Hernandez Joseph C/O CLARUS THERAPEUTICS HOLDINGS, INC. 555 SKOKIE BLVD, SUITE 340 NORTHBROOK IL 60062 1 0 0 0 Common Stock 2021-12-12 4 A 0 3844 0.00 A 3844 D Common Stock 1302500 I See Footnote Stock Option (Right to Buy) 4.78 2021-12-12 4 A 0 9610 0.00 A 2031-12-11 Common Stock 9610 9610 D The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date. Mr. Joseph Hernandez, a director and former chief executive officer of the Issuer, is the managing member of the Blue Water Sponsor LLC (the "Sponsor"). Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting. /s/ Steven A. Bourne, attorney-in-fact 2021-12-14